These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3626614)

  • 1. Blood and spleen haematopoiesis in patients with myelofibrosis.
    Douay L; Laporte JP; Lefrancois G; Najman A; Dupuy-Montbrun MC; Lopez M; Giarratana MC; Gorin NC
    Leuk Res; 1987; 11(8):725-30. PubMed ID: 3626614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of extramedullary haematopoiesis in rabbits with saponin-induced myelofibrosis and myeloid metaplasia.
    Wang JC; Tobin MS
    Br J Haematol; 1982 Jun; 51(2):277-84. PubMed ID: 7082586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
    Mesa RA; Li CY; Schroeder G; Tefferi A
    Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.
    Sagaster V; Jäger E; Weltermann A; Schwarzinger I; Gisslinger H; Lechner K; Geissler K; Oehler L
    Haematologica; 2003 Nov; 88(11):1204-12. PubMed ID: 14607748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis.
    Han ZC; Briere J; Nedellec G; Abgrall JF; Sensebe L; Parent D; Guern G
    Eur J Haematol; 1988 Feb; 40(2):130-5. PubMed ID: 3345826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the haematopoietic stem cells in primary myelofibrosis--in vitro colony forming capacity of the peripheral blood, the spleen, the splenic arterial and venous blood (author's transl)].
    Yamaguchi A; Yoshida K; Fukuda M; Fukushima Y; Sano M; Shibata A
    Rinsho Ketsueki; 1978 Mar; 19(3):221-5. PubMed ID: 702808
    [No Abstract]   [Full Text] [Related]  

  • 7. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.
    Wang X; Prakash S; Lu M; Tripodi J; Ye F; Najfeld V; Li Y; Schwartz M; Weinberg R; Roda P; Orazi A; Hoffman R
    J Clin Invest; 2012 Nov; 122(11):3888-99. PubMed ID: 23023702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia.
    Chikkappa G; Carsten AL; Chanana AD; Chandra P; Cronkite EP
    Am J Hematol; 1978; 4(2):121-31. PubMed ID: 677118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia.
    Barosi G; Rosti V; Massa M; Viarengo GL; Pecci A; Necchi V; Ramaioli I; Campanelli R; Marchetti M; Bazzan M; Magrini U
    Br J Haematol; 2004 Mar; 124(5):618-25. PubMed ID: 14871248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.
    Cesana C; Carlo-Stella C; Mangoni L; Regazzi E; Garau D; Sammarelli G; Caramatti C; Almici C; Rizzoli V
    Stem Cells; 1997; 15(3):207-13. PubMed ID: 9170212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the interactions between stromal and haematopoietic progenitor cells in expansion cell culture models.
    Bilko NM; Votyakova IA; Vasylovska SV; Bilko DI
    Cell Biol Int; 2005 Jan; 29(1):83-6. PubMed ID: 15763504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.
    Wang X; Cho SY; Hu CS; Chen D; Roboz J; Hoffman R
    Exp Hematol; 2015 Feb; 43(2):100-9.e1. PubMed ID: 25461253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term culture of peripheral blood stem cells: the effect of the addition of an irradiated stromal layer.
    Rice A; Bernard P; Foures C; Bascans E; Lacombe F; Marit G; Reiffers J
    Exp Hematol; 1989 Oct; 17(9):984-8. PubMed ID: 2570712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of splenectomy on circulating haematopoietic progenitors in myelofibrosis.
    Partanen S; Ruutu T; Juvonen E; Pantzar P
    Scand J Haematol; 1986 Aug; 37(2):87-90. PubMed ID: 3764341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia.
    Laporte JP; Douay L; Allieri A; Lopez M; Dupuy Montbrun MC; Mary JY; Giarratana MC; Isnard F; Najman A; Gorin NC
    Br J Haematol; 1990 Apr; 74(4):445-51. PubMed ID: 1971763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Splenic pathology. Case 4. Splenic extramedullary hematopoiesis revealing a myeloproliferative disease consisting with primitive myelofibrosis].
    Parrens M
    Ann Pathol; 2010 Jun; 30(3):216-22. PubMed ID: 20621600
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
    Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
    J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating granulocyte and macrophage progenitor cells in primary and secondary myelofibrosis.
    Wang JC; Cheung CP; Ahmed F; Steier W; Tobin MS
    Br J Haematol; 1983 Jun; 54(2):301-7. PubMed ID: 6849843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.